Resonance fluorescence of a trapped three-level atom

We investigate theoretically the spectrum of resonance fluorescence of a harmonically trapped atom, whose internal transitions are $\Lambda$--shaped and driven at two-photon resonance by a pair of lasers, which cool the center--of--mass motion. For this configuration, photons are scattered only due to the mechanical effects of the quantum interaction between light and atom. We study the spectrum of emission in the final stage of laser--cooling, when the atomic center-of-mass dynamics is quantum mechanical and the size of the wave packet is much smaller than the laser wavelength (Lamb--Dicke limit). We use the spectral decomposition of the Liouville operator of the master equation for the atomic density matrix and apply second order perturbation theory. We find that the spectrum of resonance fluorescence is composed by two narrow sidebands -- the Stokes and anti-Stokes components of the scattered light -- while all other signals are in general orders of magnitude smaller. For very low temperatures, however, the Mollow--type inelastic component of the spectrum becomes visible. This exhibits novel features which allow further insight into the quantum dynamics of the system. We provide a physical model that interprets our results and discuss how one can recover temperature and cooling rate of the atom from the spectrum. The behaviour of the considered system is compared with the resonance fluorescence of a trapped atom whose internal transition consists of two-levels.Comment: 11 pages, 4 Figure

Extending Quantum Links: Modules for Fiber- and Memory-Based Quantum Repeaters

We analyze elementary building blocks for quantum repeaters based on fiber channels and memory stations. Implementations are considered for three different physical platforms, for which suitable components are available: quantum dots, trapped atoms and ions, and color centers in diamond. We evaluate and compare the performances of basic quantum repeater links for these platforms both for present-day, state-of-the-art experimental parameters as well as for parameters that could in principle be reached in the future. The ultimate goal is to experimentally explore regimes at intermediate distances, up to a few 100 km, in which the repeater-assisted secret key transmission rates exceed the maximal rate achievable via direct transmission. We consider two different protocols, one of which is better adapted to the higher source clock rate and lower memory coherence time of the quantum dot platform, while the other circumvents the need of writing photonic quantum states into the memories in a heralded, non-destructive fashion. The elementary building blocks and protocols can be connected in a modular form to construct a quantum repeater system that is potentially scalable to large distances.Comment: 48 pages in Word style, "White Paper" of Q.Link.X Consortiu

Ground state cooling in a bad cavity

We study the mechanical effects of light on an atom trapped in a harmonic potential when an atomic dipole transition is driven by a laser and it is strongly coupled to a mode of an optical resonator. We investigate the cooling dynamics in the bad cavity limit, focussing on the case in which the effective transition linewidth is smaller than the trap frequency, hence when sideband cooling could be implemented. We show that quantum correlations between the mechanical actions of laser and cavity field can lead to an enhancement of the cooling efficiency with respect to sideband cooling. Such interference effects are found when the resonator losses prevail over spontaneous decay and over the rates of the coherent processes characterizing the dynamics.Comment: 6 pages, 5 figures; J. Mod. Opt. (2007

Inferring primary tumor sites from mutation spectra: a meta-analysis of histology-specific aberrations in cancer-derived cell lines

Next-generation sequencing technologies have led to profound characterization of mutation spectra for several cancer types. Hence, we sought to systematically compare genomic aberrations between primary tumors and cancer lines. For this, we compiled publically available sequencing data of 1651 genes across 905 cell lines. We used them to characterize 23 distinct primary tumor sites by a novel approach that is based on Bayesian spam-filtering techniques. Thereby, we confirmed the strong overall similarity of alterations between patient samples and cell culture. However, we also identified several suspicious mutations, which had not been associated with their cancer types before. Based on these characterizations, we developed the inferring cancer origins from mutation spectra (ICOMS) tool. On our cell line collection, the algorithm reached a prediction specificity rate of 79%, which strongly variegated between primary cancer sites. On an independent validation cohort of 431 primary tumor samples, we observed a similar accuracy of 71%. Additionally, we found that ICOMS could be employed to deduce further attributes from mutation spectra, including sub-histology and compound sensitivity. Thus, thorough classification of site-specific mutation spectra for cell lines maydecipher further genome-phenotype associations in cancer

Procedure guidelines for radioiodine therapy of differentiated thyroid cancer Version 4

The procedure guideline for radioiodine therapy of differentiated thyroid cancer (version 4) was developed in the consensus of a representative expert group. This fulfils the level S1 (first step) within the AWMF classification of Clinical Practice Guidelines (AWMF, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, Germany). This procedure guideline completed the guideline for surgical management of thyroid cancer (level S2) with the aspects from nuclear medicine. Controversies over ablative radioiodine therapy in small papillary thyroid cancers and in minimally invasive follicular cancer without angioinvasion, over empirical standard doses for ablative radioiodine therapy, and over the kind of TSH-stimulation were described and the guideline formulated a corridor of good clinical practice. The text has included the recent results from the National Cancer database and the SEER database (both from the USA), indicating that the ablative radioiodine therapy has improved the survival rate even in low risk patients. Such a statistically significant benefit can be detected only by a national cancer registry with long-term follow-up data

Lacrimal Glands May Represent Organs at Risk for Radionuclide Therapy of Prostate Cancer with [Lu-177]DKFZ-PSMA-617

Calculating the absorbed dose is important for the determination of risk and therapeutic benefit of internal radiation therapy. The aim of this study was to perform image-based absorbed dose calculation for critical organs during the first cycle of [Lu-177]DKFZ-PSMA-617 therapy in a small cohort of patients with metastatic prostate cancer. Nine patients with a history of prostate cancer documented by histopathology and radiologic evidence of metastatic diseases underwent radioligand therapy with [Lu-177]DKFZ-PSMA-617. Conjugated planar whole-body scintigraphies acquired at 0.5, 24, 48, 72, and 168 h post-injection were analyzed by regions of interest, and time-activity curves were generated for various organs. Cumulated activities and residence times were calculated by bi-exponential fit of the time-activity curves. Mean absorbed doses were finally estimated using OLINDA/EXM1.1 (TM). Additionally, the uncertainty when omitting the last measurement (168 h p.i.) was studied. The following mean absorbed doses were calculated: 2.82 mGy/MBq for the lacrimal glands, 0.72 mGy/MBq for the salivary glands, 0.53 mGy/MBq for the kidneys, and 0.42 mGy/MBq for the nasal mucous membrane. Omitting the last measurement resulted in a mean deviation of 10 to 25 % for absorbed dose values as compared to the ones received by analyzing all measurements. Absorbed organ doses of [Lu-177]DKFZ-PSMA-617 therapy are not likely to be critical for kidneys, salivary glands, and the nasal mucous membrane. The lacrimal glands may represent the dose-limiting organs. Whole-body scintigraphy appears sufficient for dose estimation, but late measurements are mandatory, if accurate dose calculation is required